Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Other Operating Expenses (2017 - 2019)

Historic Other Operating Expenses for Mimedx (MDXG) over the last 4 years, with Q4 2019 value amounting to $2.3 million.

  • Mimedx's Other Operating Expenses rose 84134.62% to $2.3 million in Q4 2019 from the same period last year, while for Sep 2020 it was $2.3 million, marking a year-over-year increase of 19010.52%. This contributed to the annual value of -$8.2 million for FY2020, which is N/A changed from last year.
  • As of Q4 2019, Mimedx's Other Operating Expenses stood at $2.3 million, which was up 84134.62% from -$2.3 million recorded in Q3 2019.
  • In the past 5 years, Mimedx's Other Operating Expenses registered a high of $2.3 million during Q4 2019, and its lowest value of -$5.3 million during Q4 2017.
  • Its 3-year average for Other Operating Expenses is -$1.1 million, with a median of -$680000.0 in 2017.
  • The largest annual percentage gain for Mimedx's Other Operating Expenses in the last 5 years was 84134.62% (2019), contrasted with its biggest fall of 237777.78% (2019).
  • Mimedx's Other Operating Expenses (Quarter) stood at -$5.3 million in 2017, then skyrocketed by 94.14% to -$312000.0 in 2018, then surged by 841.35% to $2.3 million in 2019.
  • Its Other Operating Expenses was $2.3 million in Q4 2019, compared to -$2.3 million in Q3 2019 and -$312000.0 in Q4 2018.